KPT Industries regularizes Dr. Nitin Pai as Non-Executive Director
KPT Industries Ltd has regularized the appointment of Dr. Nitin Vikas Pai as a Non-Executive Director after shareholder approval on August 8, 2026. His term began on May 29, 2026, and he is liable to retire by rotation. Dr. Pai is a senior gastroenterologist and nephew to the Non-Executive Chairperson, Mrs. Prabha Kulkarni. The move complies with SEBI LODR regulations.

*this image is generated using AI for illustrative purposes only.
KPT Industries Limited KPT Industries has regularized the appointment of Dr. Nitin Vikas Pai as a Non-Executive Director, confirming his position on the Board. Shareholders approved the regularization via a resolution passed at their meeting held on August 8, 2026. This action finalizes the governance structure for the new director, who is liable to retire by rotation.
The regularization was undertaken pursuant to Regulation 30(6), read with Schedule III Part A Para A, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified BSE Limited of the development on August 8, 2026, ensuring compliance with listing obligations regarding changes in board composition.
Director Profile and Tenure
Dr. Nitin Vikas Pai’s appointment as Non-Executive Director became effective on May 29, 2026. At 52 years of age, he brings significant professional credentials to the role. His educational background includes an MD in Medicine, DNB in Medicine, and a DM in Gastroenterology. Professionally, he serves as a senior gastroenterologist based in Pune and holds the position of Director of Gastroenterology at Ruby Hall Clinic, a prominent tertiary care institution in the region.
| Detail | Information |
|---|---|
| Name | Dr. Nitin Vikas Pai |
| Role | Non-Executive Director |
| Appointment Date | May 29, 2026 |
| Regularization Date | August 8, 2026 |
| Retirement Status | Liable to retire by rotation |
Disclosures and Relationships
In accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, the company disclosed specific relationships involving the newly appointed director. Dr. Nitin Pai is the nephew of Late Mr. Prakash Kulkarni and Mrs. Prabha Kulkarni, who serves as the Non-Executive Chairperson. He is also the brother of Dr. Ketan Vikas Pai.
The filing confirms that Dr. Pai does not fall under the purview of Section 2(76) or Section 2(77) of the Companies Act, indicating no disqualifying conditions apply. Furthermore, the company stated that he is not debarred from holding office by any regulatory authority. Aishwarya Toraskar, Company Secretary & Compliance Officer (ACS 54931), signed the intimation.
Historical Stock Returns for KPT Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.08% | +5.75% | -13.23% | -10.67% | -35.72% | +275.76% |
How might Dr. Pai's medical expertise influence KPT Industries' strategic decisions regarding healthcare sector investments or ESG compliance?
Given the familial relationship with the Non-Executive Chairperson, what specific safeguards will the board implement to ensure independent oversight and mitigate conflict of interest risks?
Will the addition of a Non-Executive Director with a healthcare background signal a potential pivot or expansion of KPT Industries into the medical services or pharmaceutical supply chain sectors?


































